Clinical values of high level HCV RNA in the diagnosis and treatment of hepatitis C patients

Yue ZHANG,Yi-qing LIU,Juan LI,Ying JU,Yong WANG,Bing-chang ZHANG,Zhen-fang DONG
DOI: https://doi.org/10.16505/j.2095-0136.2018.0015
2018-01-01
Abstract:Objective To explore the clinical value of high level HCV RNA and its correlation with biomarkers of liver function.Methods A total of 194 hepatitis C patients whose HCV RNA ≥4.0× 105 IU/ml were re cruited in the study.Serological markers such as AST,ALT,TBA,AFU,GLDH were examined.Results There were no significant differences in AST,ALT,TBA,AFU,GLDH among groups with different HCV RNA levels (P<0.05).The highest abnormal rate of liver function was AST (66.49%) and then ALT (60.82%).There were no linear correlations between HCV RNA levels and all biomarkers of liver function (P >0.05).The AUC of AST,ALT,GLDH,TBA and AFU were 0.867,0.844,0.755,0.735 and 0.613,respectively.The total AUC of biomarkers of liver function was 0.982 with the highest of specificity (99.50 %)and sensitivity (88.70%) in all biomarkers of liver function.Conclusions High level of HCV RNA should not be the single indicator for diagnosis and monitoring the efficacy of hepatitis C treatment.
What problem does this paper attempt to address?